Handelsinvest Investeringsforvaltning Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Handelsinvest Investeringsforvaltning

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 13, 2022	SELL	$83.14 - $145.99 $3.74 Million - $6.57 Million	-45,000 Closed	0 $0
Q1 2022 Apr 26, 2022	SELL	$110.08 - $142.92 $550,400 - $714,599	-5,000 Reduced 10.0%	45,000 $5.34 Million
Q1 2021 Apr 20, 2021	BUY	$64.07 - $91.75 $320,349 - $458,750	5,000 Added 11.11%	50,000 $3.42 Million
Q4 2020 Jan 25, 2021	BUY	$65.07 - $98.24 $325,349 - $491,200	5,000 Added 12.5%	45,000 $3.86 Million
Q3 2019 Oct 22, 2019	BUY	$37.38 - $49.47 $747,600 - $989,400	20,000 Added 100.0%	40,000 $1.67 Million
Q2 2019 Aug 08, 2019	BUY	$39.79 - $67.01 $795,800 - $1.34 Million	20,000 New	20,000 $876,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Handelsinvest Investeringsforvaltning, based on Form 13F filings with the SEC.

Stay updated on Handelsinvest Investeringsforvaltning with notifications on news.